Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Warren, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Bellerophon Therapeutics, Inc. has filed 643 SEC EDGAR filings since 21 Feb 2014

SEC filing history

Showing 451-475 of 643 matching filings.

Per page
25
Current page
19
8-K File 001-36845

8-K

Filing date
04 Jan 2017
Reporting date
04 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
12 Dec 2016
Reporting date
12 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88741

SC 13G/A filing

Filing date
12 Dec 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
12 Dec 2016
Reporting date
09 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Dec 2016
Reporting date
07 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Dec 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Dec 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Nov 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

FORM 8-K

Filing date
29 Nov 2016
Reporting date
22 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-214230

FINAL PROSPECTUS

Filing date
23 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS EX File 333-214230

POST-EFFECTIVE AMENDMENT NO.1

Filing date
23 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-214230

EFFECT filing

Filing date
22 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-214773

FORM S-1MEF

Filing date
22 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-214230

AMENDMENT NO. 3 TO FORM S-1

Filing date
22 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-214230

AMENDMENT NO. 2 TO FORM S-1

Filing date
21 Nov 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
15 Nov 2016
Reporting date
11 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36845

8-K

Filing date
15 Nov 2016
Reporting date
10 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .